Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06470230 · ClinicalTrials.gov registry record
RESPECT: (REsearching Stigma in PEdiatric Cancer Tool)
A clinical trial of Stigma, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 633
- Enrollment target
- 4
- Study locations
NCT06470230 is a study of Stigma that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 633 participants. The trial reports 4 study locations across 3 states.
The verdict
NCT06470230, a study of Stigma, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 633 participants
- Enrollment target
- 4
- Study locations
Study Summary
Researchers want to learn more about the way stigma affects children with cancer and their caregivers. They want to develop two clinical tools to identify and measure stigma in the pediatric cancer population within culturally diverse global settings of the United States, Guatemala, and Jordan. Primary Objectives * Develop two clinical tools that can be used to identify and measure stigma as experienced by (1) pediatric oncology patients/survivors and (2) their guardians/caregivers in culturally diverse global settings. * Pilot new stigma tools in geographically and culturally diverse cancer referral settings in the United States, Guatemala, and Jordan.
Conditions Studied
Study Locations (4)
Other
- UNOP Unidad Nacional De Oncologia Pediatrica - Guatemala City
- King Hussein Cancer Center - Amman
Missouri
- Washington University School of Public Health - St Louis
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 633 participants |
| Start Date | 2024-07-08 |
| Est. Completion | 2026-03-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06470230
The ClinicalTrials.gov registry entry for NCT06470230 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 633 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stigma appearing as the primary indexed condition, and to 0 interventions.
NCT06470230 reports 4 study locations spanning 3 distinct geographic areas - top geographies include Other, Missouri, Tennessee.
Frequently Asked Questions
What is clinical trial NCT06470230 about?
NCT06470230 is a clinical study titled "RESPECT: (REsearching Stigma in PEdiatric Cancer Tool)". Researchers want to learn more about the way stigma affects children with cancer and their caregivers. They want to develop two clinical tools to identify and measure stigma in the pediatric cancer population within culturally diverse global settings of the United States, Guatemala, and Jordan. Pri...
What is the current status of trial NCT06470230?
This trial is currently completed. The enrollment target is 633 participants. The study started on 2024-07-08. Estimated completion is 2026-03-06.
What conditions does trial NCT06470230 study?
This clinical trial studies the following conditions: Stigma.
Who is sponsoring clinical trial NCT06470230?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06470230 being conducted?
This trial has 4 study locations across Missouri, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stigma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.